Sam Brusco, Associate Editor10.11.22
ZEISS Medical Technology has gained U.S. Food and Drug Administration (FDA) 510(k) clearance for its MTLawton disposable polar forceps for electrosurgery.
The forceps are made of a copper-base alloy and can potentially reduce tissue adhesion and subsequent charring during tissue dissection. The extended shaft also helps to lower visual restrictions in the surgical field and boost efficiency.
The development of the new bipolar forceps is based on close collaboration with Michael T. Lawton, one of the world's leading neurosurgeons.
"The MTLawton Disposable Bipolar Forceps are a real advance in electrosurgery over aluminum forceps. Our copper-base alloy has superior thermal conduction to improve cautery-based hemostasis and reduce tissue adhesion," Lawton, MD, who is president and CEO, Chair, Department of Neurosurgery, Barrow Neurological Institute, told the press. "I take these MTLawton bipolars into battle with all my difficult arteriovenous malformations, and they give me a noticeable advantage."
The improved material conducts heat away from the silver-plated tips more quickly to potentially reduce tissue adhesion and charring. The MTLawton allows clear view of the cauterization area, even in narrow and deep cavities.
"With the acquisition of Kogent Surgical in April 2022, ZEISS has expanded its range of surgical solutions for microsurgery. We are pleased to be able to introduce the first surgical instrument from this acquisition to the market with FDA approval for MTLawton," said Dr. Markus Weber, CEO of Carl Zeiss Meditec.
The forceps are made of a copper-base alloy and can potentially reduce tissue adhesion and subsequent charring during tissue dissection. The extended shaft also helps to lower visual restrictions in the surgical field and boost efficiency.
The development of the new bipolar forceps is based on close collaboration with Michael T. Lawton, one of the world's leading neurosurgeons.
"The MTLawton Disposable Bipolar Forceps are a real advance in electrosurgery over aluminum forceps. Our copper-base alloy has superior thermal conduction to improve cautery-based hemostasis and reduce tissue adhesion," Lawton, MD, who is president and CEO, Chair, Department of Neurosurgery, Barrow Neurological Institute, told the press. "I take these MTLawton bipolars into battle with all my difficult arteriovenous malformations, and they give me a noticeable advantage."
The improved material conducts heat away from the silver-plated tips more quickly to potentially reduce tissue adhesion and charring. The MTLawton allows clear view of the cauterization area, even in narrow and deep cavities.
"With the acquisition of Kogent Surgical in April 2022, ZEISS has expanded its range of surgical solutions for microsurgery. We are pleased to be able to introduce the first surgical instrument from this acquisition to the market with FDA approval for MTLawton," said Dr. Markus Weber, CEO of Carl Zeiss Meditec.